Orexigenic effects of endomorphin-2 (em-2) related to decreased crh gene expression and increased dopamine and norepinephrine activity in the hypothalamus

Peptides

Volumn 48, Issue , 2013, Pages 83-88

  Brunetti, Luigi ^a   Ferrante, Claudio ^a   Orlando, Giustino ^a   Recinella, Lucia ^a   Leone, Sheila ^a   Chiavaroli, Annalisa ^a   Di Nisio, Chiara ^a   Shohreh, Rugia ^a   Manippa, Fabio ^a   Ricciuti, Adriana ^a   Mollica, Adriano ^a   Vacca, Michele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Corticotrophin releasing hormone; Dopamine; Endomorphin 2; Feeding; Hypothalamus; Norepinephrine

Indexed keywords

COMPLEMENTARY DNA; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; ENDOMORPHIN 2; MESSENGER RNA; MU OPIATE RECEPTOR; NEUROPEPTIDE Y; NORADRENALIN; OREXIN A; PROOPIOMELANOCORTIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APPETITE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA EXTRACTION;

AGOUTI; RATTUS; RATTUS NORVEGICUS;

5-HT; AGOUTI-RELATED PEPTIDE; AGRP; ARC; ARCUATE NUCLEUS; CART; COCAINE AND AMPHETAMINE-REGULATED TRANSCRIPT; CORTICOTROPHIN RELEASING HORMONE; CORTICOTROPHIN-RELEASING HORMONE; CRH; DA; DOPAMINE; EM-2; ENDOMORPHIN-2; FEEDING; HYPOTHALAMUS; NE; NEUROPEPTIDE Y; NOREPINEPHRINE; NPY; PARAVENTRICULAR NUCLEUS; POMC; PRO-OPIOMELANOCORTIN; PVN; REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REAL-TIME RT PCR; SEROTONIN;

AGOUTI-RELATED PROTEIN; ANIMALS; ARCUATE NUCLEUS; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NALTREXONE; NERVE TISSUE PROTEINS; NEUROPEPTIDE Y; NEUROPEPTIDES; NOREPINEPHRINE; OLIGOPEPTIDES; PRO-OPIOMELANOCORTIN; RATS; SEROTONIN;

EID: 84883182366     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.07.021     Document Type: Article

References (42)

1. Asakawa A, Inui A, Momose K, Ueno N, Fujino MA, Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. Neuroreport 1998;9:2265-7. (Pubitemid 28338218)
2. Asakawa A, Inui A, Ueno N, Fujimiya M, Fujino MA, Kasuga M. Endomorphin-1, an endogenous mu-opioid receptor-selective agonist, stimulates oxygen consumption in mice. Hormone and Metabolic Research 2000;32:51-2. (Pubitemid 30143607)
3. Barnes MJ, Holmes G, Primeaux SD, York DA, Bray GA. Increased expression of mu opioid receptors in animals susceptible to diet-induced obesity. Peptides 2006;27:3292-8. (Pubitemid 44738177)
4. Bodnar RJ, Klein GE. Endogenous opiates and behavior: 2004. Peptides 2005;26:2629-711. (Pubitemid 41676742)
5. Brunetti L, Di Nisio C, Recinella L, Chiavaroli A, Leone S, Ferrante C, et al. Effects of vaspin, chemerin and omentin-1 on feeding behavior and hypothalamic peptide gene expression in the rat. Peptides 2011;32:1866-71.
6. Brunetti L, Di Nisio C, Orlando G, Ferrante C, Vacca M. The regulation of feeding: a cross talk between peripheral and central signalling. International Journal of Immunopathology and Pharmacology 2005;18:201-12. (Pubitemid 40825883)
7. Brunetti L, Michelotto B, Orlando G, Vacca M. Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings. European Journal of Pharmacology 1999;372:237-40. (Pubitemid 29255963)
8. Brunetti L, Orlando G, Ferrante C, Chiavaroli A, Vacca M, Peptide YY. (3-36) inhibits dopamine and norepinephrine release in hypothalamus. European Journal of Pharmacology 2005;519:48-51. (Pubitemid 43181163)
9. Brunetti L, Orlando G, Recinella L, Michelotto B, Ferrante C, Vacca M. Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus. European Journal of Pharmacology 2004;493:41-4. (Pubitemid 38746930)
10. Brunetti L, Orlando G, Ferrante C, Recinella L, Leone S, Chiavaroli A, et al. Orexigenic effects of omentin-1 related to decreased CART and CRH gene expression and increased norepinephrine synthesis and release in the hypothalamus. Peptides 2013;44:66-74.
11. Brunetti L, Recinella L, Di Nisio C, Chiavaroli A, Leone S, Ferrante C, et al. Effects of visfatin/PBEF/NAMPT on feeding behavior and hypothalamic neuromodulators in the rat. Journal of Biological Regulators & Homeostatic Agents 2012;26:295-302.
12. Bujdosó E, Jászberényi M, Tömböly C, Tóth G, Telegdy G. Behavioral and neuroendocrine actions of endomorphin-2. Peptides 2001;22:1459-63. (Pubitemid 32770018)
13. Bungo T, Shiraishi J, Yanagita K, Ohta Y, Fujita M. Effect of nociceptin/orphanin FQ on feeding behavior and hypothalamic neuropeptide expression in layertype chicks. General and Comparative Endocrinology 2009;163:47-51.
14. Clark KA, MohanKumar SMJ, Kasturi BS, MohanKumar PS. Effects of central and systemic administration of leptin on neurotransmitter concentrations in specific areas of the hypothalamus. American Journal of Physiology Regulatory Integrative and Comparative Physiology 2006;290:306-12.
15. Fichna J, Janecka A, Piestrzeniewicz M, Costentin J, do Rego JC. Antidepressantlike effect of endomorphin-1 and endomorphin-2 in mice. Neuropsychipharmacology 2007;32:813-21. (Pubitemid 46426170)
16. Gillard ER, Dang DQ, Stanley BG. Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Brain Research 1993;628:128-36. (Pubitemid 23331601)
17. Giraudo SQ, Grace MK, Billington CJ, Levine AS. Differential effects of neuropeptide Y and the mu-agonist DAMGO on 'palatability' vs. 'energy'. Brain Research 1999;83:160-3. (Pubitemid 29332023)
18. Glass MJ, Billington CJ, Levine AS. Opioids and food intake: distributed functional neural pathways. Neuropeptides 1999;33:360-8. (Pubitemid 29530128)
19. Gosnell BA. Central structures involved in opioid-induced feeding. Federation Proceedings 1987;46:163-7. (Pubitemid 17056337)
20. Grandison L, Guidotti A. Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology 1977;16:533-6. (Pubitemid 8138715)
21. Hackler L, Zadina JE, Ge LJ, Kastin AJ. Isolation of relatively large amounts of endomorphin-1 and EM-2 from human brain cortex. Peptides 1997;18:1635-9. (Pubitemid 28133009)
22. Hosohata K, Burkey TH, Alfaro-Lopez J, Varga E, Hruby VJ, Roeske WR, et al. Endomorphin-1 and EM-2 are partial agonists at the human mu-opioid receptor. European Journal of Pharmacology 1998;346:111-4. (Pubitemid 28197096)
23. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetiteregulating pathways in the hypothalamic regulation of body weight. Endocrine Reviews 1999;20:68-100. (Pubitemid 29092036)
24. Leibowitz SF. Hypothalamic paraventricular nucleus: interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance. Neuroscience & Biobehavioral Reviews 1988;12: 101-9. (Pubitemid 19268743)
25. Levine AS, Morley JE. Neuropeptide Y: a potent inducer of consummatory behaviour in rats. Peptides 1984;5:1025-9. (Pubitemid 15135925)
26. Levine AS, Weldon DT, Grace M, Cleary JP, Billington CJ. Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. American Journal of Physiology 1995;268:248-52.
27. Levine AS, Atkinson RL. Opioids in the regulation of food intake and energy expenditure. Federation Proceedings 1987;46:159-62. (Pubitemid 17056336)
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(?Delta Delta C(T)). Method Methods 2001;25:402-8. (Pubitemid 34164012)
29. Martin-Schild S, Gerall AA, Kastin AJ, Zadina JE. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. Journal of Comparative Neurology 1999;405: 450-71. (Pubitemid 29124064)
30. Okutsu H, Watanabe S, Takahashi I, Aono Y, Saigusa T, Koshikawa N, et al. Endomorphin-2 and endomorphin-1 promote the extracellular amount of accumbal dopamine via nonopioid and mu-opioid receptors, respectively. Neuropsychopharmacology 2006;31:375-83. (Pubitemid 43113401)
31. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. New York: Academic Press; 2007.
32. Perlikowska R, do-Rego JC, Cravezic A, Fichna J, Wyrebska A, Toth G, et al. Synthesis and biological evaluation of cyclic endomorphin-2 analogs. Peptides 2010;31:339-45.
33. Samanin R, Garattini S. Neurochemical mechanism of action of anorectic drugs. Pharmacology & Toxicology 1993;73:63-8. (Pubitemid 23278474)
34. Sánchez E, Rubio VC, Thompson D, Metz J, Flik G, Millhauser GL, et al. Phosphodiesterase inhibitor-dependent inverse agonism of agouti-related protein on melanocortin 4 receptor in sea bass (Dicentrarchus labrax). American Journal of Physiology Regulatory Integrative and Comparative Physiology 2009;296:1293-306.
35. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-71. (Pubitemid 30205071)
36. Stanley BG, Schwartz DH, Hernandez L, Hoebel BG, Leibowitz SF. Patterns of extracellular norepinephrine in the paraventricular hypothalamus: relationship to circadian rhythm and deprivation-induced eating behavior. Life Sciences 1989;45:275-82. (Pubitemid 19196595)
37. Tseng LF. The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse. Japanese Journal of Pharmcology 2002;89: 216-20.
38. Vaccarino FJ, Taube MR. Intra-arcuate opiate actions stimulate GRF-dependent and protein-selective feeding. Peptides 1997;18:197-205. (Pubitemid 27224384)
39. Valassi E, Scacchi M, Cavagnini F. Neuroendocrine control of food intake. Nutrition, Metabolism & Cardiovascular Diseases 2008;18:158-68. (Pubitemid 351282471)
40. Wellman PJ, Davies BT, Morien A, McMahon L. Modulation of feeding by hypothalamic paraventricular nucleus-1- and-2-adrenergic receptors. Life Sciences 1993;53:669-79.
41. Yang ZJ, Meguid MM. LHA dopamine activity in obese and Zucker rats. NeuroReport 1995;6:1191-4.
42. Zadina JE, Hackler L, Ge LJ, Kastin AJ. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 1997;386:499-502. (Pubitemid 27164076)